Inspire Medical Systems (INSP) Receives $41.63 Average Price Target from Analysts
Inspire Medical Systems (NASDAQ:INSP) has been given a consensus rating of “Hold” by the nine research firms that are covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, three have given a hold rating and five have issued a buy rating on the company. The average twelve-month target price among analysts that have covered the stock in the last year is $41.63.
Several research analysts have recently commented on INSP shares. Zacks Investment Research cut shares of Inspire Medical Systems from a “hold” rating to a “sell” rating in a report on Wednesday, November 21st. Berenberg Bank started coverage on shares of Inspire Medical Systems in a report on Wednesday, November 28th. They set a “sell” rating and a $31.00 target price on the stock. Finally, Dougherty & Co started coverage on shares of Inspire Medical Systems in a report on Tuesday, February 5th. They set a “buy” rating and a $64.00 target price on the stock.
In related news, CEO Timothy P. Herbert sold 15,000 shares of Inspire Medical Systems stock in a transaction that occurred on Tuesday, December 18th. The shares were sold at an average price of $42.88, for a total value of $643,200.00. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Casey M. Tansey sold 25,000 shares of Inspire Medical Systems stock in a transaction that occurred on Thursday, March 7th. The shares were sold at an average price of $54.78, for a total transaction of $1,369,500.00. The disclosure for this sale can be found here. Insiders sold 845,054 shares of company stock worth $43,724,104 over the last three months.
Shares of INSP opened at $57.19 on Thursday. Inspire Medical Systems has a 12 month low of $22.50 and a 12 month high of $64.34.
Inspire Medical Systems (NASDAQ:INSP) last announced its earnings results on Tuesday, February 26th. The company reported ($0.22) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.32) by $0.10. The business had revenue of $16.56 million for the quarter, compared to the consensus estimate of $15.42 million. The firm’s revenue was up 66.3% compared to the same quarter last year.
About Inspire Medical Systems
Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
Recommended Story: The mechanics of the bid-ask spread in trading
Receive News & Ratings for Inspire Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Inspire Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.